Observational Studies Requested by European Health Authorities: Governmental Interference or an Enhancement of Everyday Urological Practice? The Hexvix® Observational Patients Evaluation Study as an Example of What to Expect.

Date publication

août 2017

Journal

Urologia internationalis

Auteurs

Membres identifiés du Cancéropôle Est :
Pr JACQMIN Didier

Tous les auteurs :
Jacqmin D, Jichlinski P, Molinier L, de la Taille A, Irani J, Malavaud B

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/28787725

Résumé

The Hexvix® Observational Patients Evaluation (HOPE) study was designed to determine the extent of distribution of the use of hexaminolevulinate in the diagnosis of non-muscle invasive bladder cancer (NMIBC) and assess patient and treatment characteristics associated with different endoscopic modalities and to address the French authorities' request for information on routine practices for NMIBC diagnosis and surveillance.

Mots clés

European Union regulation, Hexaminolevulinate, Non-muscle invasive bladder cancer, Observational studies

Référence

Urol. Int.. 2017 Aug;: